HEADER HYDROLASE/HYDROLASE INHIBITOR 09-JAN-20 6VH2 TITLE 2.26 A RESOLUTION STRUCTURE OF MERS 3CL PROTEASE IN COMPLEX WITH TITLE 2 INHIBITOR 7I COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORF1A PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_TAXID: 1335626; SOURCE 5 GENE: ORF1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS PROTEASE, MERS 3CL PROTEASE INHHIBITORS, HYDROLASE, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LOVELL,K.P.BATTAILE,M.M.KASHIPATHY,A.D.RATHNAYAKE,J.ZHENG,Y.KIM, AUTHOR 2 H.N.NGUYEN,K.O.CHANG,W.C.GROUTAS REVDAT 4 11-OCT-23 6VH2 1 REMARK REVDAT 3 02-SEP-20 6VH2 1 JRNL REVDAT 2 19-AUG-20 6VH2 1 JRNL REVDAT 1 12-AUG-20 6VH2 0 JRNL AUTH A.D.RATHNAYAKE,J.ZHENG,Y.KIM,K.D.PERERA,S.MACKIN, JRNL AUTH 2 D.K.MEYERHOLZ,M.M.KASHIPATHY,K.P.BATTAILE,S.LOVELL, JRNL AUTH 3 S.PERLMAN,W.C.GROUTAS,K.O.CHANG JRNL TITL 3C-LIKE PROTEASE INHIBITORS BLOCK CORONAVIRUS REPLICATION IN JRNL TITL 2 VITRO AND IMPROVE SURVIVAL IN MERS-COV-INFECTED MICE. JRNL REF SCI TRANSL MED V. 12 2020 JRNL REFN ESSN 1946-6242 JRNL PMID 32747425 JRNL DOI 10.1126/SCITRANSLMED.ABC5332 REMARK 2 REMARK 2 RESOLUTION. 2.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_3913 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.07 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.310 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 33452 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.790 REMARK 3 FREE R VALUE TEST SET COUNT : 1601 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.0700 - 5.0100 1.00 3082 152 0.1772 0.2030 REMARK 3 2 5.0100 - 3.9800 1.00 2949 163 0.1335 0.1814 REMARK 3 3 3.9800 - 3.4800 1.00 2911 140 0.1636 0.2424 REMARK 3 4 3.4800 - 3.1600 1.00 2902 145 0.1804 0.2538 REMARK 3 5 3.1600 - 2.9300 1.00 2881 159 0.2184 0.3154 REMARK 3 6 2.9300 - 2.7600 1.00 2879 148 0.2103 0.2791 REMARK 3 7 2.7600 - 2.6200 0.99 2883 128 0.2041 0.3032 REMARK 3 8 2.6200 - 2.5100 0.99 2844 148 0.2092 0.3045 REMARK 3 9 2.5100 - 2.4100 1.00 2856 151 0.2301 0.3136 REMARK 3 10 2.4100 - 2.3300 0.99 2839 132 0.2383 0.3347 REMARK 3 11 2.3300 - 2.2600 0.99 2825 135 0.2522 0.3358 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6VH2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1000246364. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-AUG-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33514 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.256 REMARK 200 RESOLUTION RANGE LOW (A) : 45.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.12800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.91800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: 5WKK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% (W/V) PEG 4000, 100 MM SODIUM REMARK 280 CITRATE, 100 MM MAGNESIUM CHLORIDE, PH 5.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.01400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.38850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.54900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.38850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.01400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.54900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A 73 REMARK 465 ALA A 74 REMARK 465 PRO A 75 REMARK 465 MET A 301 REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 VAL A 304 REMARK 465 MET A 305 REMARK 465 GLN A 306 REMARK 465 MET B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 GLY B 73 REMARK 465 ALA B 74 REMARK 465 PRO B 75 REMARK 465 VAL B 304 REMARK 465 MET B 305 REMARK 465 GLN B 306 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 0 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 5 CD CE NZ REMARK 470 MET A 25 CG SD CE REMARK 470 ASP A 47 CG OD1 OD2 REMARK 470 GLN A 48 CG CD OE1 NE2 REMARK 470 LYS A 70 CE NZ REMARK 470 ILE A 72 CG1 CG2 CD1 REMARK 470 ARG A 79 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 91 CE NZ REMARK 470 LYS A 110 CE NZ REMARK 470 ARG A 124 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 140 CE NZ REMARK 470 GLU A 156 CD OE1 OE2 REMARK 470 VAL A 196 CG1 CG2 REMARK 470 GLN A 197 CD OE1 NE2 REMARK 470 LYS A 201 CE NZ REMARK 470 LYS A 224 CE NZ REMARK 470 GLU A 235 CD OE1 OE2 REMARK 470 GLN A 249 CG CD OE1 NE2 REMARK 470 LYS A 279 CE NZ REMARK 470 MET A 286 SD CE REMARK 470 GLU A 288 CG CD OE1 OE2 REMARK 470 MET A 298 CG SD CE REMARK 470 LYS B 5 CE NZ REMARK 470 ASP B 47 CG OD1 OD2 REMARK 470 GLN B 48 CG CD OE1 NE2 REMARK 470 GLN B 69 CD OE1 NE2 REMARK 470 LYS B 70 CG CD CE NZ REMARK 470 ILE B 72 CG1 CG2 CD1 REMARK 470 ARG B 79 CD NE CZ NH1 NH2 REMARK 470 LYS B 110 CE NZ REMARK 470 ARG B 124 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 140 CE NZ REMARK 470 LYS B 155 CE NZ REMARK 470 GLU B 156 CD OE1 OE2 REMARK 470 HIS B 194 CG ND1 CD2 CE1 NE2 REMARK 470 VAL B 196 CG1 CG2 REMARK 470 LYS B 224 CE NZ REMARK 470 GLN B 249 CG CD OE1 NE2 REMARK 470 LYS B 257 CD CE NZ REMARK 470 LYS B 279 CE NZ REMARK 470 MET B 286 SD CE REMARK 470 GLU B 288 CG CD OE1 OE2 REMARK 470 MET B 298 SD CE REMARK 470 VAL B 303 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -126.20 50.10 REMARK 500 GLN A 48 46.38 -107.96 REMARK 500 ASP A 51 74.52 -157.53 REMARK 500 LYS A 140 -106.77 -88.28 REMARK 500 ASP B 33 -123.49 48.28 REMARK 500 HIS B 41 0.35 -69.48 REMARK 500 HIS B 71 -56.18 -133.24 REMARK 500 LYS B 140 -112.55 -86.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QZ4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide QZ4 B 401 and CYS B REMARK 800 148 DBREF1 6VH2 A 1 306 UNP A0A1L2E0X0_9BETC DBREF2 6VH2 A A0A1L2E0X0 3248 3553 DBREF1 6VH2 B 1 306 UNP A0A1L2E0X0_9BETC DBREF2 6VH2 B A0A1L2E0X0 3248 3553 SEQADV 6VH2 MET A -6 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS A -5 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS A -4 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS A -3 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS A -2 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS A -1 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS A 0 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 MET B -6 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS B -5 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS B -4 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS B -3 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS B -2 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS B -1 UNP A0A1L2E0X EXPRESSION TAG SEQADV 6VH2 HIS B 0 UNP A0A1L2E0X EXPRESSION TAG SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER GLY LEU VAL LYS MET SEQRES 2 A 313 SER HIS PRO SER GLY ASP VAL GLU ALA CYS MET VAL GLN SEQRES 3 A 313 VAL THR CYS GLY SER MET THR LEU ASN GLY LEU TRP LEU SEQRES 4 A 313 ASP ASN THR VAL TRP CYS PRO ARG HIS VAL MET CYS PRO SEQRES 5 A 313 ALA ASP GLN LEU SER ASP PRO ASN TYR ASP ALA LEU LEU SEQRES 6 A 313 ILE SER MET THR ASN HIS SER PHE SER VAL GLN LYS HIS SEQRES 7 A 313 ILE GLY ALA PRO ALA ASN LEU ARG VAL VAL GLY HIS ALA SEQRES 8 A 313 MET GLN GLY THR LEU LEU LYS LEU THR VAL ASP VAL ALA SEQRES 9 A 313 ASN PRO SER THR PRO ALA TYR THR PHE THR THR VAL LYS SEQRES 10 A 313 PRO GLY ALA ALA PHE SER VAL LEU ALA CYS TYR ASN GLY SEQRES 11 A 313 ARG PRO THR GLY THR PHE THR VAL VAL MET ARG PRO ASN SEQRES 12 A 313 TYR THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS GLY SEQRES 13 A 313 SER VAL GLY TYR THR LYS GLU GLY SER VAL ILE ASN PHE SEQRES 14 A 313 CYS TYR MET HIS GLN MET GLU LEU ALA ASN GLY THR HIS SEQRES 15 A 313 THR GLY SER ALA PHE ASP GLY THR MET TYR GLY ALA PHE SEQRES 16 A 313 MET ASP LYS GLN VAL HIS GLN VAL GLN LEU THR ASP LYS SEQRES 17 A 313 TYR CYS SER VAL ASN VAL VAL ALA TRP LEU TYR ALA ALA SEQRES 18 A 313 ILE LEU ASN GLY CYS ALA TRP PHE VAL LYS PRO ASN ARG SEQRES 19 A 313 THR SER VAL VAL SER PHE ASN GLU TRP ALA LEU ALA ASN SEQRES 20 A 313 GLN PHE THR GLU PHE VAL GLY THR GLN SER VAL ASP MET SEQRES 21 A 313 LEU ALA VAL LYS THR GLY VAL ALA ILE GLU GLN LEU LEU SEQRES 22 A 313 TYR ALA ILE GLN GLN LEU TYR THR GLY PHE GLN GLY LYS SEQRES 23 A 313 GLN ILE LEU GLY SER THR MET LEU GLU ASP GLU PHE THR SEQRES 24 A 313 PRO GLU ASP VAL ASN MET GLN ILE MET GLY VAL VAL MET SEQRES 25 A 313 GLN SEQRES 1 B 313 MET HIS HIS HIS HIS HIS HIS SER GLY LEU VAL LYS MET SEQRES 2 B 313 SER HIS PRO SER GLY ASP VAL GLU ALA CYS MET VAL GLN SEQRES 3 B 313 VAL THR CYS GLY SER MET THR LEU ASN GLY LEU TRP LEU SEQRES 4 B 313 ASP ASN THR VAL TRP CYS PRO ARG HIS VAL MET CYS PRO SEQRES 5 B 313 ALA ASP GLN LEU SER ASP PRO ASN TYR ASP ALA LEU LEU SEQRES 6 B 313 ILE SER MET THR ASN HIS SER PHE SER VAL GLN LYS HIS SEQRES 7 B 313 ILE GLY ALA PRO ALA ASN LEU ARG VAL VAL GLY HIS ALA SEQRES 8 B 313 MET GLN GLY THR LEU LEU LYS LEU THR VAL ASP VAL ALA SEQRES 9 B 313 ASN PRO SER THR PRO ALA TYR THR PHE THR THR VAL LYS SEQRES 10 B 313 PRO GLY ALA ALA PHE SER VAL LEU ALA CYS TYR ASN GLY SEQRES 11 B 313 ARG PRO THR GLY THR PHE THR VAL VAL MET ARG PRO ASN SEQRES 12 B 313 TYR THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS GLY SEQRES 13 B 313 SER VAL GLY TYR THR LYS GLU GLY SER VAL ILE ASN PHE SEQRES 14 B 313 CYS TYR MET HIS GLN MET GLU LEU ALA ASN GLY THR HIS SEQRES 15 B 313 THR GLY SER ALA PHE ASP GLY THR MET TYR GLY ALA PHE SEQRES 16 B 313 MET ASP LYS GLN VAL HIS GLN VAL GLN LEU THR ASP LYS SEQRES 17 B 313 TYR CYS SER VAL ASN VAL VAL ALA TRP LEU TYR ALA ALA SEQRES 18 B 313 ILE LEU ASN GLY CYS ALA TRP PHE VAL LYS PRO ASN ARG SEQRES 19 B 313 THR SER VAL VAL SER PHE ASN GLU TRP ALA LEU ALA ASN SEQRES 20 B 313 GLN PHE THR GLU PHE VAL GLY THR GLN SER VAL ASP MET SEQRES 21 B 313 LEU ALA VAL LYS THR GLY VAL ALA ILE GLU GLN LEU LEU SEQRES 22 B 313 TYR ALA ILE GLN GLN LEU TYR THR GLY PHE GLN GLY LYS SEQRES 23 B 313 GLN ILE LEU GLY SER THR MET LEU GLU ASP GLU PHE THR SEQRES 24 B 313 PRO GLU ASP VAL ASN MET GLN ILE MET GLY VAL VAL MET SEQRES 25 B 313 GLN HET QZ4 A 401 33 HET QZ4 B 401 33 HETNAM QZ4 4,4-DIFLUOROCYCLOHEXYL [(2S)-3-CYCLOHEXYL-1-({(2S)-1- HETNAM 2 QZ4 HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPAN-2- HETNAM 3 QZ4 YL}AMINO)-1-OXOPROPAN-2-YL]CARBAMATE FORMUL 3 QZ4 2(C23 H37 F2 N3 O5) FORMUL 5 HOH *198(H2 O) HELIX 1 AA1 SER A 10 ALA A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 ASN A 53 SER A 60 1 8 HELIX 4 AA4 THR A 62 HIS A 64 5 3 HELIX 5 AA5 MET A 184 PHE A 188 5 5 HELIX 6 AA6 CYS A 203 ASN A 217 1 15 HELIX 7 AA7 SER A 229 ASN A 240 1 12 HELIX 8 AA8 THR A 248 GLY A 259 1 12 HELIX 9 AA9 ALA A 261 TYR A 273 1 13 HELIX 10 AB1 THR A 292 ILE A 300 1 9 HELIX 11 AB2 SER B 10 ALA B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 PRO B 45 LEU B 49 5 5 HELIX 14 AB5 ASN B 53 MET B 61 1 9 HELIX 15 AB6 THR B 62 PHE B 66 5 5 HELIX 16 AB7 CYS B 203 ASN B 217 1 15 HELIX 17 AB8 SER B 229 ALA B 239 1 11 HELIX 18 AB9 THR B 248 GLY B 259 1 12 HELIX 19 AC1 ALA B 261 TYR B 273 1 13 HELIX 20 AC2 THR B 292 ILE B 300 1 9 SHEET 1 AA1 7 ASN A 77 LEU A 78 0 SHEET 2 AA1 7 PHE A 66 GLN A 69 -1 N VAL A 68 O LEU A 78 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O SER A 67 SHEET 4 AA1 7 MET A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 THR A 35 PRO A 39 -1 O THR A 35 N LEU A 32 SHEET 6 AA1 7 LEU A 89 VAL A 94 -1 O LEU A 90 N CYS A 38 SHEET 7 AA1 7 VAL A 80 GLN A 86 -1 N ALA A 84 O LYS A 91 SHEET 1 AA2 5 TYR A 104 PHE A 106 0 SHEET 2 AA2 5 VAL A 159 GLU A 169 1 O PHE A 162 N THR A 105 SHEET 3 AA2 5 VAL A 151 GLU A 156 -1 N GLY A 152 O CYS A 163 SHEET 4 AA2 5 ALA A 114 TYR A 121 -1 N SER A 116 O TYR A 153 SHEET 5 AA2 5 ARG A 124 VAL A 132 -1 O PHE A 129 N VAL A 117 SHEET 1 AA3 3 TYR A 104 PHE A 106 0 SHEET 2 AA3 3 VAL A 159 GLU A 169 1 O PHE A 162 N THR A 105 SHEET 3 AA3 3 HIS A 175 SER A 178 -1 O SER A 178 N MET A 165 SHEET 1 AA4 7 ASN B 77 LEU B 78 0 SHEET 2 AA4 7 SER B 67 GLN B 69 -1 N VAL B 68 O LEU B 78 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O SER B 67 SHEET 4 AA4 7 MET B 25 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 5 AA4 7 THR B 35 PRO B 39 -1 O THR B 35 N LEU B 32 SHEET 6 AA4 7 LEU B 89 VAL B 94 -1 O LEU B 92 N VAL B 36 SHEET 7 AA4 7 VAL B 80 GLN B 86 -1 N GLN B 86 O LEU B 89 SHEET 1 AA5 5 TYR B 104 PHE B 106 0 SHEET 2 AA5 5 VAL B 159 GLU B 169 1 O PHE B 162 N THR B 105 SHEET 3 AA5 5 VAL B 151 GLU B 156 -1 N THR B 154 O ASN B 161 SHEET 4 AA5 5 ALA B 114 TYR B 121 -1 N SER B 116 O TYR B 153 SHEET 5 AA5 5 ARG B 124 VAL B 132 -1 O PHE B 129 N VAL B 117 SHEET 1 AA6 3 TYR B 104 PHE B 106 0 SHEET 2 AA6 3 VAL B 159 GLU B 169 1 O PHE B 162 N THR B 105 SHEET 3 AA6 3 HIS B 175 SER B 178 -1 O SER B 178 N MET B 165 LINK SG CYS A 148 C28 QZ4 A 401 1555 1555 1.81 LINK SG CYS B 148 C28 QZ4 B 401 1555 1555 1.82 SITE 1 AC1 17 TYR A 54 PHE A 143 GLY A 146 SER A 147 SITE 2 AC1 17 CYS A 148 HIS A 166 GLN A 167 MET A 168 SITE 3 AC1 17 GLU A 169 HIS A 175 ASP A 190 LYS A 191 SITE 4 AC1 17 GLN A 192 VAL A 193 HIS A 194 GLN A 195 SITE 5 AC1 17 GLY A 278 SITE 1 AC2 19 LEU B 27 ASN B 28 HIS B 41 TYR B 54 SITE 2 AC2 19 PHE B 143 GLY B 146 SER B 147 GLY B 149 SITE 3 AC2 19 SER B 150 HIS B 166 GLN B 167 MET B 168 SITE 4 AC2 19 GLU B 169 LEU B 170 HIS B 175 ASP B 190 SITE 5 AC2 19 LYS B 191 GLN B 192 HOH B 567 CRYST1 76.028 91.098 100.777 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013153 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010977 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009923 0.00000